Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahnaz Shekari

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Prevention of Alzheimer'S Disease|August 12, 2025
Blood pressure and Alzheimer's disease biomarkers in cognitively unimpaired adults: a multicenter studyMariona Osset-Malla, Aitana Martínez-Velasco, Gonzalo Sánchez-Benavides, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2024
Centiloid recommendations for clinical context-of-use from the AMYPAD consortiumLyduine E Collij, Ariane Bollack, Renaud La Joie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challengesAriane Bollack, Mahnaz Shekari, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progressionWiesje Pelkmans, Mahnaz Shekari, Anna Brugulat-Serrat, et al.
Alzheimer'S Research & Therapy|August 6, 2021
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuumNatalia Vilor-Tejedor, Iacopo Ciampa, Grégory Operto, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 26, 2023
Genetic, vascular and amyloid components of cerebral blood flow in a preclinical populationBeatriz E Padrela, Luigi Lorenzini, Lyduine E Collij, et al.
Brain Communications|June 15, 2022
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markersGemma Salvadó, Mahnaz Shekari, Carles Falcon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2022
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuumGemma Salvadó, Marta Milà-Alomà, Mahnaz Shekari, et al.
Alzheimer'S Research & Therapy|September 6, 2022
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid?Muge Akinci, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, et al.
The Journal of Prevention of Alzheimer'S Disease|June 8, 2026
Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer's diseaseDavid López-Martos, Raffaele Cacciaglia, Marc Suárez-Calvet, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Prevention of Alzheimer'S Disease|August 12, 2025
Blood pressure and Alzheimer's disease biomarkers in cognitively unimpaired adults: a multicenter studyMariona Osset-Malla, Aitana Martínez-Velasco, Gonzalo Sánchez-Benavides, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2024
Centiloid recommendations for clinical context-of-use from the AMYPAD consortiumLyduine E Collij, Ariane Bollack, Renaud La Joie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challengesAriane Bollack, Mahnaz Shekari, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progressionWiesje Pelkmans, Mahnaz Shekari, Anna Brugulat-Serrat, et al.
Alzheimer'S Research & Therapy|August 6, 2021
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuumNatalia Vilor-Tejedor, Iacopo Ciampa, Grégory Operto, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 26, 2023
Genetic, vascular and amyloid components of cerebral blood flow in a preclinical populationBeatriz E Padrela, Luigi Lorenzini, Lyduine E Collij, et al.
Brain Communications|June 15, 2022
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markersGemma Salvadó, Mahnaz Shekari, Carles Falcon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2022
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuumGemma Salvadó, Marta Milà-Alomà, Mahnaz Shekari, et al.
Alzheimer'S Research & Therapy|September 6, 2022
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid?Muge Akinci, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, et al.
The Journal of Prevention of Alzheimer'S Disease|June 8, 2026
Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer's diseaseDavid López-Martos, Raffaele Cacciaglia, Marc Suárez-Calvet, et al.
Pageof 6